Health Trials

Trastuzumab Deruxtecan

2

Review clinical trials related to Trastuzumab Deruxtecan. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea

Prospective observational study of trastuzumab emtansine immediately after trastuzumab deruxtecan in patients with advanced HER2-positive breast cancer in Korea

Participants needed: 100
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Seoul National University HospitalUpdated: Apr 23, 2026Locations: 1
Eligibility criteria

HER2-positive, advanced (unresectable locally advanced or metastatic) breast can... [+2]

Any systemic treatment, other than T-DM1, for breast cancer after trastuzumab de... [+3]

Read more
Status: Recruiting

A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients

This multi-center observational retrospective study will collect real-world clinical data from eligible patients with unresectable or metastatic HER2+ breast cancer who have received one or more cycles Trastuzumab Deruxtecan in Russian Federation

Participants needed: 60
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Blokhin's Russian Cancer Research CenterUpdated: Dec 15, 2025Locations: 1
Eligibility criteria

Patients aged over 18 years old. [+3]

Incomplete medical history. [+1]

Read more